LGLinda Garcés-Ramírez

Linda Garcés-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Linda Garcés-Ramírez has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhanced recognition memory, spatial learning and operant conditioning by chronic administration of 1,3-di-o-tolylguanidine in Wistar rat

    by Jimena N. Torres-Mendoza, Gabriela Silva-Luna, Dulce E. Nicolás-Álvarez, María del Rocío Elizabeth Ortiz-Butrón, Fidel De La Cruz-López, Linda Garcés-Ramírez

    Sigma chaperone proteins, including sigma-1 (σ-1R) and sigma-2 (σ-2R) receptors, are key regulators of cellular homeostasis and neurotransmission. These proteins are primarily localized in the endoplasmic reticulum and mitochondria-associated membranes, where they regulate calcium signaling, energy metabolism, and synaptic plasticity. Through modulation of voltage- and ligand-gated ion channels, including calcium channels and NMDA receptors, sigma proteins have emerged as promising therapeutic targets in neurodegenerative and cognitive impairment models. However, their role under physiological conditions in healthy subjects remains poorly understood. Therefore, this study evaluated the effects of chronic administration of the non-selective sigma receptor agonist 1,3-di-o-tolylguanidine (DTG) on different forms of learning in experimentally naive, cognitively intact rats. Male Wistar rats received DTG (10 mg/kg) or vehicle for 21 days and were evaluated using the novel object recognition test, operant conditioning in the Skinner box, and the Barnes maze. DTG treatment did not alter locomotor activity. In the novel object recognition task, DTG-treated rats showed increased discrimination index and exploration time during acquisition and memory phases. In operant conditioning, DTG significantly increased lever pressing during acquisition, indicating facilitation of reinforcement learning. In the Barnes maze, both groups exhibited similar spatial learning; however, DTG-treated rats employed more efficient search strategies. Overall, chronic DTG administration induced subtle but consistent cognitive enhancement without affecting motor performance, suggesting a positive modulatory role of sigma chaperone proteins on learning and memory under physiological conditions.

  • Quetiapine treatment corrects behavioral impairments and promotes neuroplasticity in a neurodevelopmental rat model of schizophrenia

    by Francisco Javier Cabrera-Pedraza, David J. Apam-Castillejos, Fidel de la Cruz-López, Linda Garcés-Ramírez, Hiram Tendilla-Beltrán, Gonzalo Flores


  • Open Access

    Current Status and Challenges of Stem Cell Treatment for Alzheimer’s Disease

    by Mar Pacheco-Herrero, Luis O. Soto-Rojas, Heidy Reyes-Sabater, Linda Garcés-Ramirez, Fidel de la Cruz López, Ignacio Villanueva-Fierro, José Luna-Muñoz

    Neurodegenerative diseases called tauopathies, such as Alzheimer’s disease (AD), frontotemporal dementia, progressive supranuclear palsy, and Parkinson’s disease, among others, are characterized by the pathological processing and accumulation of tau protein. AD is the most prevalent neurodegenerative disease and is characterized by two lesions: neurofibrillary tangles (NFTs) and neuritic plaques. The presence of NFTs in the hippocampus and neocortex in early and advanced stages, respectively, correlates with the patient’s cognitive deterioration. So far, no drugs can prevent, decrease, or limit neuronal death due to abnormal pathological tau accumulation. Among potential non-pharmacological treatments, physical exercise has been shown to stimulate the development of stem cells (SCs) and may be useful in early stages. However, this does not prevent neuronal death from the massive accumulation of NFTs. In recent years, SCs therapies have emerged as a promising tool to repopulate areas involved in cognition in neurodegenerative diseases. Unfortunately, protocols for SCs therapy are still being developed and the mechanism of action of such therapy remains unclear. In this review, we show the advances and limitations of SCs therapy. Finally, we provide a critical analysis of its clinical use for AD.


  • National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in México

    by Aldelmo Emmanuel Reyes-Pablo, B Berenice Campa-Córdoba, Nabil Itzi Luna-Viramontes, Miguel Ángel Ontiveros-Torres, Ignacio Villanueva-Fierro, Marely Bravo-Muñoz, Bárbara Sáenz-Ibarra, Oralia Barbosa, Parménides Guadarrama-Ortíz, Linda Garcés-Ramírez, et al.

    We recently developed the National Dementia Biobank in México (BioBanco Nacional de Demencias, BND) as a unit for diagnosis, research, and tissue transfer for research purposes. BND is associated with the Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de Mexico (UNAM), Mexico. The donation of fluids, brain, and other organs of deceased donors is crucial for understanding the underlying mechanisms of neurodegenerative diseases and for the development of successful treatment. Our laboratory research focuses on 1) analysis of the molecular processing of the proteins involved in those neurodegenerative diseases termed tauopathies and 2) the search for biomarkers for the non-invasive and early diagnosis of Alzheimer’s disease.


  • Open Access

    Intranigral Administration of β ‐Sitosterol‐ β ‐D‐Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra

    by Claudia Luna-Herrera, Irma A. Martínez-Dávila, Luis O. Soto-Rojas, Yazmin M. Flores-Martinez, Manuel A. Fernandez-Parrilla, Jose Ayala-Davila, Bertha A. León-Chavez, Guadalupe Soto-Rodriguez, Victor M. Blanco-Alvarez, Francisco E. Lopez-Salas, et al.

    Chronic consumption of β ‐sitosterol‐ β ‐D‐glucoside (BSSG), a neurotoxin contained in cycad seeds, leads to Parkinson’s disease in humans and rodents. Here, we explored whether a single intranigral administration of BSSG triggers neuroinflammation and neurotoxic A1 reactive astrocytes besides dopaminergic neurodegeneration. We injected 6 μ g BSSG/1 μ L DMSO or vehicle into the left substantia nigra and immunostained with antibodies against tyrosine hydroxylase (TH) together with markers of microglia (OX42), astrocytes (GFAP, S100 β , C3), and leukocytes (CD45). We also measured nitric oxide (NO), lipid peroxidation (LPX), and proinflammatory cytokines (TNF‐ α , IL‐1 β , IL‐6). The Evans blue assay was used to explore the blood‐brain barrier (BBB) permeability. We found that BSSG activates NO production on days 15 and 30 and LPX on day 120. Throughout the study, high levels of TNF‐ α were present in BSSG‐treated animals, whereas IL‐1 β was induced until day 60 and IL‐6 until day 30. Immunoreactivity of activated microglia (899.0 ± 80.20 % ) and reactive astrocytes (651.50 ± 11.28 % ) progressively increased until day 30 and then decreased to remain 251.2 ± 48.8 % (microglia) and 91.02 ± 39.8 (astrocytes) higher over controls on day 120. C3(+) cells were also GFAP and S100 β immunoreactive, showing they were neurotoxic A1 reactive astrocytes. BBB remained permeable until day 15 when immune cell infiltration was maximum. TH immunoreactivity progressively declined, reaching 83.6 ± 1.8 % reduction on day 120. Our data show that BSSG acute administration causes chronic neuroinflammation mediated by activated microglia, neurotoxic A1 reactive astrocytes, and infiltrated immune cells. The severe neuroinflammation might trigger Parkinson’s disease in BSSG intoxication.


  • Open Access

    Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion

    by Hiram Tendilla-Beltrán, Silvia Meneses-Prado, Rubén Antonio Vázquez-Roque, Miguel Tapia-Rodríguez, Andrea Judith Vázquez-Hernández, Heriberto Coatl-Cuaya, David Martín-Hernández, Karina S. MacDowell, Linda Garcés-Ramírez, Juan C. Leza, et al.

    Reduction of the dendritic arbor length and the lack of dendritic spines in the pyramidal cells of the prefrontal cortex (PFC) are prevalent pathological features in schizophrenia (SZ). Neonatal ventral hippocampus lesion (NVHL) in male rats reproduces these neuronal characteristics and here we describe how this is a consequence of BDNF/TrkB pathway disruption. Moreover, COX-2 proinflammatory state, as well as Nrf-2 antioxidant impairment, triggers oxidative/nitrosative stress, which also contributes to dendritic spine impairments in the PFC. Interestingly, oxidative/nitrosative stress was also detected in the periphery of NVHL animals. Furthermore, risperidone treatment had a neurotrophic effect on the PFC and antioxidant effects on the brain and periphery of NVHL animals; these cellular effects were related to behavioral improvement. Our data highlight the link between brain development and immune response, as well as several other factors to understand mechanisms related to the pathophysiology of SZ.SIGNIFICANCE STATEMENTPrefrontal cortex dysfunction in schizophrenia can be a consequence of morphological abnormalities and oxidative/nitrosative stress, among others. Here, we detailed how impaired plasticity-related pathways and oxidative/nitrosative stress are part of the dendritic spine pathology and their modulation by atypical antipsychotic risperidone treatment in rats with neonatal ventral hippocampus lesion. Moreover, we found that animals with neonatal ventral hippocampus lesion had oxidative/nitrosative stress in the brain as well as in the peripheral blood, an important issue for the translational approaches of this model. Then, risperidone restored plasticity and reduced oxidative/nitrosative stress of prefrontal cortex pyramidal cells, and ultimately improved the behavior of lesioned animals. Moreover, risperidone had differential effects than the brain on peripheral blood oxidative/nitrosative stress.


  • Open Access

    Effects of Acute Administration of Sigma Receptor Ligands on Mesolimbic Dopamine Neurotransmission in Rats

    by Gianluigi Tanda, Linda Garcés‐Ramírez, Jennifer L Green, Takato Hiranita, Jonathan L Katz

    Sigma receptors (σRs) can modulate cocaine's behavioral effects, which are related to increased mesolimbic dopamine (DA) neurotransmission, and σR agonists can maintain responding in rats that self administer cocaine. We report here effects of σR ligands on DA transmission in rats implanted with vertical microdialysis probes in the nucleus accumbens shell. Cocaine (0.1‐1.0 mg/kg iv) or a non‐selective σ 1/2 agonist (DTG: 1.0‐5.6 mg/kg iv) dose‐dependently increased DA levels to 275 and 150% of baseline, respectively. In contrast, the preferential σ 1 R agonist, PRE‐084 (0.32‐3.2 mg/kg iv), did not significantly modify DA levels. The preferential σ 1 R antagonist, BD 1063 (10‐30 mg/kg ip), administered alone transiently (1/2 antagonist, BD 1008 (10 mg/kg ip) modestly decreased DA levels over the 2 hr following its administration. The effects of 5.6 mg/kg DTG were attenuated by BD 1008 (10 mg/kg ip), but not by BD 1063 (10‐30 mg/kg ip). In sum, the results show that acute administration of σR ligands can increase DA transmission in a brain area involved in the reinforcing effects of cocaine, and this effect appears to be mediated by the σ 2 R. Studies are in progress to understand if σR ligands can also modulate cocaine‐induced stimulation of DA transmission.